Myeloproliferative Neoplasm Research Consortium (MPN-RC) Report issue

Academic/Hospital Phase 1

Organization Overview

First Clinical Trial
2019
NCT03895112
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Myeloproliferative Neoplasm Research Consortium (MPN-RC)

Active Ingredients

Drugs in Phase 1 Trials (1)

avid200 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Polycythemia (Phase 1)

Polycythemia Vera (Phase 1)

Primary Myelofibrosis (Phase 1)

Thrombocythemia, Essential (Phase 1)

Thrombocytosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1